- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-dimer
- Ligands
- 2 x X5O: denifanstat(Non-covalent)
- 4 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
NDP.2: 25 residues within 4Å:- Chain A: F.720, V.798, T.801, S.822, S.824, G.825, G.826, V.827, G.828, V.846, G.847, K.851, S.870, R.871, I.916, K.918, V.941, L.942, L.943, M.990, A.991, Q.992, G.993, H.995, G.997
19 PLIP interactions:19 interactions with chain A- Hydrophobic interactions: A:T.801
- Hydrogen bonds: A:S.822, A:S.822, A:S.824, A:S.824, A:G.826, A:V.827, A:G.828, A:G.847, A:K.851, A:S.870, A:V.941, A:L.943, A:M.990, A:G.997
- Salt bridges: A:K.851, A:R.871, A:H.995
- pi-Stacking: A:H.995
NDP.3: 30 residues within 4Å:- Chain A: G.1038, L.1040, G.1041, G.1042, F.1043, T.1062, S.1063, R.1064, S.1065, R.1068, N.1092, N.1117, L.1118, A.1119, V.1120, V.1121, P.1141, K.1142, F.1166, S.1167, S.1168, Y.1181, W.1207, G.1208, A.1209, I.1210, G.1214, I.1215, L.1216
- Ligands: X5O.1
19 PLIP interactions:19 interactions with chain A- Hydrophobic interactions: A:W.1207, A:I.1210
- Hydrogen bonds: A:G.1038, A:L.1040, A:G.1042, A:F.1043, A:S.1063, A:R.1064, A:S.1065, A:N.1092, A:N.1092, A:L.1118, A:V.1120, A:K.1142, A:K.1142, A:Y.1181, A:I.1210, A:I.1215
- Salt bridges: A:R.1064
NDP.5: 26 residues within 4Å:- Chain B: F.720, V.798, T.801, S.822, S.824, G.825, G.826, V.827, G.828, V.846, G.847, K.851, S.870, R.871, S.894, I.916, K.918, V.941, L.942, L.943, M.990, A.991, Q.992, G.993, H.995, G.997
20 PLIP interactions:20 interactions with chain B- Hydrophobic interactions: B:T.801, B:I.916
- Hydrogen bonds: B:S.822, B:S.822, B:S.824, B:S.824, B:G.826, B:V.827, B:G.828, B:G.847, B:K.851, B:S.870, B:V.941, B:L.943, B:M.990, B:G.997
- Salt bridges: B:K.851, B:R.871, B:H.995
- pi-Stacking: B:H.995
NDP.6: 29 residues within 4Å:- Chain B: G.1038, L.1040, G.1041, G.1042, F.1043, T.1062, S.1063, R.1064, S.1065, N.1092, N.1117, L.1118, A.1119, V.1120, V.1121, P.1141, K.1142, F.1166, S.1167, S.1168, Y.1181, W.1207, G.1208, A.1209, I.1210, G.1214, I.1215, L.1216
- Ligands: X5O.4
19 PLIP interactions:19 interactions with chain B- Hydrophobic interactions: B:W.1207, B:I.1210
- Hydrogen bonds: B:G.1038, B:L.1040, B:G.1042, B:F.1043, B:S.1063, B:R.1064, B:S.1065, B:N.1092, B:N.1092, B:L.1118, B:V.1120, B:K.1142, B:K.1142, B:Y.1181, B:I.1210, B:I.1215
- Salt bridges: B:R.1064
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hasan, S.M.N. et al., Atomic model for core modifying region of human fatty acid synthase in complex with Denifanstat. Nat Commun (2023)
- Release Date
- 2023-05-24
- Peptides
- Fatty acid synthase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
D
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-dimer
- Ligands
- 2 x X5O: denifanstat(Non-covalent)
- 4 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hasan, S.M.N. et al., Atomic model for core modifying region of human fatty acid synthase in complex with Denifanstat. Nat Commun (2023)
- Release Date
- 2023-05-24
- Peptides
- Fatty acid synthase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
D